Meta-analyses of several randomized controlled trials have confirmed that increased serum levels of TGF-β1 and CysC are associated with an elevated risk of DKD (19, 20), highlighting their significance in the onset and progression of DKD. This evidence concerns the gene TGFB1 and diabetic kidney disease.